Logo image
Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2
Journal article   Open access   Peer reviewed

Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2

Evan Diamond, Melanie Amen, Qiaoyan Hu, Herbert M. Espinoza and Brad A. Amendt
Nucleic acids research, Vol.34(20), pp.5951-5965
11/01/2006
DOI: 10.1093/nar/gkl689
PMCID: PMC1635299
PMID: 17068080
url
https://doi.org/10.1093/nar/gkl689View
Published (Version of record) Open Access

Abstract

Dlx2, Lymphoid Enhancer Factor (Lef-1) and Msx2 transcription factors are required for several developmental processes. To understand the control of gene expression by these factors, chromatin immunoprecipitation (ChIP) assays identified Msx2 as a downstream target of Dlx2 and Lef-1. Dlx2 activates the Msx2 promoter in several cell lines and binds DNA as a monomer and dimer. A Lef-1 beta-catenin-dependent isoform minimally activates the Msx2 promoter and a Lef-1 beta-catenin-independent isoform is inactive, however co-expression of Dlx2 and both Lef-1 isoforms synergistically activate the Msx2 promoter. Co-immunoprecipitation and protein pull-down experiments demonstrate Lef-1 physically interacts with Dlx2. Deletion analyses of the Lef-1 protein reveal specific regions required for synergism with Dlx2. The Lef-1 beta-catenin binding domain (beta DB) is not required for its interaction with Dlx2. Msx2 can auto-regulate its promoter and repress Dlx2 activation. Msx2 repression of Dlx2 activation is dose-specific and both bind a common DNA-binding element. These transcriptional mechanisms correlate with the temporal and spatial expression of these factors and may provide a mechanism for the control of several developmental processes. We demonstrate new transcriptional activities for Dlx2, Msx2 and Lef-1 through protein interactions and identification of downstream targets.
Biochemistry & Molecular Biology Life Sciences & Biomedicine Science & Technology

Details

Metrics

Logo image